← Back to Search

Online Communication Modalities for Genetic Results Communication (BWHS RoR Trial)

N/A
Recruiting
Led By Catharine Wang, PhD
Research Sponsored by Boston University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Women in the BWHS previously included in the targeted breast cancer sequencing project
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

BWHS RoR Trial Summary

This trial examines the efficiency of an online program to provide genetic results to African American women, helping to provide personal health information & increase access to precision medicine.

Who is the study for?
This trial is for African American women who were part of the BWHS breast cancer sequencing project. It's not open to those with uncertain genetic test results or known cognitive impairments.Check my eligibility
What is being tested?
The study tests an online self-guided program for returning genetic results related to certain cancers, comparing it with follow-up by a genetic counselor. The goal is to find scalable ways to share health information effectively.See study design
What are the potential side effects?
Since this trial involves informational interventions rather than medical treatments, traditional physical side effects are not applicable. However, participants may experience stress or anxiety from learning about their genetic risks.

BWHS RoR Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I was part of the breast cancer sequencing project in the BWHS.

BWHS RoR Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Anxiety at 12 months
Anxiety
Change from baseline in breast cancer genetics knowledge based on questionnaire at responses at 6 weeks
+12 more

BWHS RoR Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Online modalityExperimental Treatment2 Interventions
Online self-guided modality entails return of genetic results directly to participants, with optional genetic counselor follow-up via telephone.
Group II: Conventional modalityActive Control1 Intervention
Control arm. Conventional modality entails telephone disclosure of genetic results by a licensed genetic counselor.

Find a Location

Who is running the clinical trial?

National Institute on Minority Health and Health Disparities (NIMHD)NIH
382 Previous Clinical Trials
1,213,886 Total Patients Enrolled
MGH Institute of Health ProfessionsOTHER
15 Previous Clinical Trials
1,380 Total Patients Enrolled
University of WashingtonOTHER
1,739 Previous Clinical Trials
1,845,667 Total Patients Enrolled

Media Library

Online modality Clinical Trial Eligibility Overview. Trial Name: NCT04407611 — N/A
Breast and Ovarian Cancer Research Study Groups: Conventional modality, Online modality
Breast and Ovarian Cancer Clinical Trial 2023: Online modality Highlights & Side Effects. Trial Name: NCT04407611 — N/A
Online modality 2023 Treatment Timeline for Medical Study. Trial Name: NCT04407611 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are the elderly being considered as potential participants in this experiment?

"The eligibility requirements of this trial dictate that only individuals between the ages of 40 and 74 are allowed to participate."

Answered by AI

What demographic is eligible to take part in this clinical exploration?

"This trial necessitates that individuals have Lynch Syndrome and must be within the age range of 40 to 74. Currently, 2275 participants are being sought out for this study."

Answered by AI

Are candidates currently being admitted to this research endeavor?

"Affirmative. The clinicaltrials.gov database indicates that this study is currently recruiting, having been initiated on March 6th 2023 and most recently updated on the 27th of the same month. This research project requires 2275 patients to be enrolled at a single centre."

Answered by AI

What is the upper limit for participant numbers in this study?

"Affirmative. According to clinicaltrials.gov, this medical experiment posted on March 6th 2023 is currently recruiting applicants. Updating as recently as the 27th of March, it seeks 2250 participants from a single facility."

Answered by AI
~796 spots leftby Dec 2024